ASII... Best month with over $4 million in Revs.... Finally News on every month has been a record breaker. Stock price is at a great entry of .0006.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175510018

$CBDW Update from Twitter (X): CBDW.ai | A Brand by 1606 Corp@CBDWInc
Take a look at the newest blog from 1606 Corp.
December 2, 2024
https://x.com/CBDWInc/status/1863615332855808111

1606 Corp. (OTC: CBDW) stands at the forefront of technological innovation, particularly in AI Chatbots. Our mission is to revolutionize customer service, addressing the most significant challenges faced by consumers in the digital marketplace. We are dedicated to transforming the IR industry through cutting-edge AI centric solutions, ensuring a seamless and efficient customer experience.

As a visionary enterprise, 1606 Corp. equips businesses with the advanced tools they need to excel in the competitive digital landscape. Our commitment to innovation and quality positions us as a leader in the field, driving the industry forward and setting new benchmarks for success and customer satisfaction.

For more information, please visit http://www.cbdw.ai

$ACGX: Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023

No New Free Trading Shares have been issued for over 8 months

CHICAGO, Nov. 14, 2024 /PRNewswire/ -- Alliance Creative Group, Inc., (http://www.ACGX.us) (Stock Symbol OTC: ACGX) is pleased to announce the results of Operations for the Quarter Ending September 30, 2024.

Revenues for the Quarter ending September 30, 2024 ("Q3 2024") were $102,990 Gross Profits for the Quarter ending September 30, 2024 ("Q3 2024") were $102,990 Net Income for the Quarter ending September 30, 2024 ("Q3 2024") were ($44,912)

The total assets on the Balance Sheet for the Alliance Creative Group as of 9/30/24 were $4,543,643

The total outstanding common shares as of September 30, 2024 were 4,454,211 with 2,799,023 of those shares in the float - Same as the end of the last quarter, and since March.

The Company ended the quarter with $88,220 Cash on hand.

The property located at 1324 W. Devon Ave, Chicago, IL. 60660 has lowered its asking pricing and hopes to sell before the end of the year.

The full financial statement, balance sheet, statement of operations, cash flow statement, and disclosure statements are posted on the OTC Market Company website at http://www.OTCmarkets.com under the stock symbol ACGX in the section for filings and disclosure and on http://www.ACGX,us in the investor relations section.

Paul Sorkin, CEO of the Alliance Creative Group, Inc. said, "We continue to look for future opportunities, however, nothing has been a good fit yet. Our goal is to reduce the price significantly with the 1324 W. Devon Ave property so we can sell it before the end of the year and increase our search for the next opportunity. Our shares of www.PeopleVine.com continue to be by far our strongest investment and the conversations with the growth capital investment groups have been avery positive experience with lots of interest. Our goal is to convert between 20% and 30% of the PeopleVine investment into cash in 2025 so we can use a lot of it to invest in future projects while we let the majority of the shares hopefully continue to increase in value.

We haven't issued any new free trading shares in over 8 months now and we are still in search of other strategic investments, acquisitions, or partnerships in Real Estate or in a small business with good potential to grow. We will continue to update the public as things progress and will share more details as they become available."

About Alliance Creative Group, Inc.

Alliance Creative Group, Inc. (Stock Symbol: ACGX) is a Parent Holding Company on the OTC market. The strategy ACG intends to deploy is a shared resource model where internal divisions, portfolio companies, Real Estate projects, and strategic investments are vertically integrated, optimizing efficiencies and cost savings. Resources may be applied to a mix of early-stage equity investments in companies that synergize with the company's shared resource model and secured investment opportunities. ACG's strategic mission is to utilize a unique blend of capital, relationships, experience, and secured investment structures to increase value for its clients, partners, investors, and shareholders while reducing the overall risk. The company's big picture long term plan is to create an ecosystem of shared resources that can provide quality resources with reduced expenses while acting as a partner for internal projects. The intent is to have multiple businesses and investment projects or divisions to help diversify the risk and generate potential revenue in multiple ways while leveraging both the private and public markets. For more information, visit http://www.AllianceCreativeGroup.com or http://www.ACGX.us.

About PeopleVine

PeopleVine is a Software as a Service (SAAS) company that specializes in serving the Lifestyle Hospitality industry. The Member Experience & CRM Software allows luxury hotels, resorts, and private member clubs to elevate a more personalized online membership experience. PeopleVine helps their clients build member communities, drive engagement, and connect the dots that elevate experiences and revenues. The software empowers its clients teams to deliver efficiently managed operations through an integrated platform. PeopleVine is committed to being the most essential and adaptive SaaS engagement platform for companies that take a customer centric approach to business.

For more information http://www.PeopleVine.com

This news release contains forward-looking statements as defined by the bespeaks-caution doctrine. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks described in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Investor Relations and Media Contact

1-312-498-9769, info@ACGemail.com

Cision View original content:https://www.prnewswire.com/news-releases/alliance-creative-group-acgx-releases-q3-2024-financial-and-disclosure-report-with-an-increase-of-over-100-in-net-income-for-1st-9-months-of-2024-vs-2023-302304712.html

SOURCE Alliance Creative Group, Inc.

$SHPH Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient
https://www.globenewswire.com/news-release/2024/11/26/2987539/0/en/Shuttle-Pharma-Expands-Patient-Enrollment-for-Phase-2-Clinical-Trial-of-Ropidoxuridine-for-Treatment-of-Patients-with-Glioblastoma-as-UVA-Cancer-Center-Doses-Its-First-Patient.html

$CBDW Update from X: Explore the most recent blog from 1606.https://x.com/CBDWInc/status/1861414723524108558

1606 Corp. stands at the forefront of technological innovation, particularly in AI Chatbots. Our mission is to revolutionize customer service, addressing the most significant challenges faced by consumers in the digital marketplace. We are dedicated to transforming the IR industry through cutting-edge AI centric solutions, ensuring a seamless and efficient customer experience.

As a visionary enterprise, 1606 Corp. equips businesses with the advanced tools they need to excel in the competitive digital landscape. Our commitment to innovation and quality positions us as a leader in the field, driving the industry forward and setting new benchmarks for success and customer satisfaction.

For more information, please visit http://www.cbdw.ai

$idta seems very memeable. ~4 million float. Headlines sound amazing, but company has done next to nothing for over a decade.

$OPWEF Opawica Announces the Closing of Final Tranche of Oversubscribed Non-Brokered Private Placement
https://www.otcmarkets.com/stock/OPWEF/news/story?e&id=3057265

$HRAL Hear At Last Holdings, (HRAL) Has Contracted with Canadian Heritage to Manage the Installation of Their Hohm Sales
https://www.newsfilecorp.com/release/230469

$CBDW News: 1606 Corp. AI Chatbots Innovations, Highlights Adnexus LOI, and Quarterly Reporting Update After Q3 Filling

SEATTLE, WA / ACCESSWIRE / November 19, 2024 / 1606 Corp. (OTC PINK:CBDW) (the "Company," or "1606") has made strong progress in the latest quarter, positioning itself as a key player in the growing AI chatbot market. The Company has focused on expanding its product offerings, forging strategic partnerships, and investing in innovative AI technology that enhances user interactions across industries. A key milestone for the Q3 includes strategic partnerships with Adnexus, marking a significant leap in the Company's AI-driven solutions.

Key Developments:

Quarterly SEC reporting:

We are excited to announce that we have filed our 10-Q for the quarter ended September 30, 2024. This filing reflects our commitment to transparency and regulatory compliance, providing investors and shareholders with detailed insights into our financial performance and operational activities. We are proud that we have been able to stay current with all fillings since our inception three years ago.

Expansion of Market Reach:
Throughout the quarter, we made substantial efforts to increase our market reach into the rapidly growing demand for AI-driven customer service and automation tools. We are committed to exploring new opportunities for expansion, particularly in sectors such as e-commerce, finance, healthcare, and telecommunications, where AI-powered chatbots are increasingly in demand. We have already created two chatbots that can be tested at cbdw.ai

Ongoing AI Innovation and Product Development:
Innovation remains at the core of our strategy, with a continuous focus on improving our AI chatbot capabilities. By integrating more advanced machine learning models and NLP techniques, we aim to provide highly personalized, human-like interactions for businesses and consumers alike.

Strategic Partnership with Adnexus Biotechnologies:
We signed a Letter of Intent (LOI) with Adnexus Biotechnologies, a leading firm in AI and biotechnology solutions. This potential strategic investment underscores our commitment to expanding our technological footprint and enhancing our capabilities in the rapidly evolving field of AI. We believe the integration of Adnexus's cutting-edge AI research and development expertise would significantly bolster our portfolio, bringing advanced solutions to the intersection of artificial intelligence and healthcare and biotech.

CEO Statement

Austen Lambrecht, CEO of 1606 Corp., commented, "This has been a transformative quarter for 1606 Corp. With the successful filing of our third consecutive Quarterly Report, we continue to demonstrate our commitment to transparency and regulatory compliance. A key milestone for Q3 was the signing of our Letter of Intent with Adnexus Biotechnologies, which opens exciting new opportunities in the AI sector." Lambrechht continued, "We're building a strong foundation for long-term growth by expanding our technological capabilities and forging strategic partnerships. I'm incredibly proud of our team's progress and look forward to further advancing our mission of innovation and excellence in the months ahead."

Outlook for the Next Quarter:

Looking ahead, 1606 Corp's focus will be on:

Closing Strategic Investment with Adnexus: We will be focused on closing the investment in Adnexus Biotechnologies.
Expanding AI Chatbot Solutions: We will continue to enhance our AI capabilities, with plans to launch additional AI-powered chatbot solutions that offer businesses even more advanced tools for automation, customer service, and engagement.
Growing Market Presence: Through the partnership with Adnexus, we aim to expand our reach into new verticals, such as healthcare, finance, and telecommunications, where AI chatbots are rapidly becoming essential for operational efficiency.
Increased Revenue from AI Chatbots: As AI solutions like Chat IR gain traction, we expect to see a rise in demand for our products, which we believe will contribute to revenue growth in the next quarter.
About 1606 Corp.

1606 Corp. stands at the forefront of technological innovation, particularly in AI Chatbots. Our mission is to revolutionize customer service, addressing the most significant challenges faced by consumers in the digital marketplace. We are dedicated to transforming the IR industry through cutting-edge AI centric solutions, ensuring a seamless and efficient customer experience.

As a visionary enterprise, 1606 Corp. equips businesses with the advanced tools they need to excel in the competitive digital landscape. Our commitment to innovation and quality positions us as a leader in the field, driving the industry forward and setting new benchmarks for success and customer satisfaction.

For more information, please visit http://www.cbdw.ai.

Industry Information

The global AI market, valued at $428 billion in 2022, is anticipated to reach $2.25 trillion by 2030, with a compound annual growth rate (CAGR) ranging from 33.2% to 38.1%. The sector is expected to employ 97 million individuals by 2025, reflecting its expansive and significant impact. This potential growth presents a compelling opportunity for investors and industry professionals interested in the AI sector.

Forward-Looking Statements

This press release includes forward-looking statements under federal securities laws, including projections and expectations regarding business developments, operations, and market conditions. These statements are identified by terms such as "should," "may," "intends," "anticipates," and others. While based on reasonable assumptions, results may differ due to various risks and uncertainties. Please review cautionary statements and disclosures in our filings with the SEC. The Company does not undertake any obligation to update forward-looking statements except as required by law.

Contact Information

Austen Lambrecht
CEO
austen@1606corp.com

SOURCE: 1606 Corp

$CBDW 1606 Corp. Unveils New AI Vertical: IR Chat, a Bot for Public Companies and Investors
https://cbdw.ai/news/1606-corp-unveils-new-ai-vertical-ir-chat-a-bot-for-public-companies-and-investors/

$CBDW News: 1606 Corp. Target for Strategic Investment Adnexus Biotechnologies Merges With Sanctum Therapeutics to Obtain Breakthrough HIV and SARS-CoV-2 Treatments

SEATTLE, WA / ACCESSWIRE / November 12, 2024 / 1606 Corp. (OTC PINK:CBDW) (the "Company" or "1606"), a leader in AI technology, acquisition target Adnexus Biotechnologies Inc. is delighted to reveal the completion of a merger agreement to acquire Sanctum Therapeutics core technology assets for treating HIV and SARS-CoV-2. This merger will combine the two biotechnology companies' significant resources and expertise. The combination of resources and expertise significantly enhance the research capabilities of Adnexus's HIV and SARS-CoV-2 research.

Adnexus Biotechnologies Inc. is poised to revolutionize its HIV and infectious disease portfolio with the acquisition of Sanctum Therapeutics' leading-edge assets. This strategic merger combines Adnexus's state-of-the-art AI-driven drug discovery platform with Sanctum's innovative long-acting HIV capsid inhibitor and Adnexus's short-acting anti-HIV monoclonal antibodies. Together, these therapies offer a potent, dual-action approach that enhances treatment efficacy, reduces the risk of viral resistance, and provides a promising new option for HIV patients.

The acquisition further strengthens Adnexus's position in the rapidly growing market for HIV treatments, while also expanding its pipeline of drug candidates targeting antimicrobial-resistant infections and other infectious diseases. With Sanctum's advanced inhibitors and expertise in navigating the FDA regulatory landscape, Adnexus is uniquely positioned to accelerate the development of high-impact therapies.

Austen Lambrecht, CEO of 1606 Corp., commented, "The merger between Adnexus Biotechnologies and Sanctum Therapeutics marks a pivotal moment in the fight against HIV and other infectious diseases. By combining Adnexus's cutting-edge AI-driven drug discovery platform with Sanctum's breakthrough therapies, they are not only advancing the development of life-saving treatments but also driving forward our mission to leverage technological innovation for the betterment of global healthcare. Lambrecht continued, "This strategic partnership underscores our commitment to supporting transformative biotech advancements, and we are excited to play a role in helping bring these therapies to market for those who need them most."

This synergistic combination of resources, along with Adnexus's cutting-edge Sutra AI Drug Discovery Platform, creates a powerful foundation for continued innovation and growth, ultimately delivering significant value for patients and shareholders alike.

Adnexus has recently executed a Letter of Intent with the Company for a strategic investment by the Company for 5% of Adnexus. The LOI terminates on November 27, 2024 and has an option to extend.

About Adnexus Biotechnologies Inc.

Adnexus is a leading innovator in biotechnology, specializing in AI-driven solutions for early drug discovery, infectious disease and neurodegenerative disease research. Its proprietary methods focus on developing therapeutic solutions by leveraging human immune-B cells, offering a cutting-edge approach to creating highly effective treatments. For more information, please visit https://www.adnexusbiotech.com.

About 1606 Corp.

1606 Corp. stands at the forefront of technological innovation, particularly in AI Chatbots. Our mission is to revolutionize customer service, addressing the most significant challenges faced by consumers in the digital marketplace. We are dedicated to transforming the IR industry through cutting-edge AI centric solutions, ensuring a seamless and efficient customer experience.

As a visionary enterprise, 1606 Corp. equips businesses with the advanced tools they need to excel in the competitive digital landscape. Our commitment to innovation and quality positions us as a leader in the field, driving the industry forward and setting new benchmarks for success and customer satisfaction.

For more information, please visit cbdw.ai

Industry Information

The global AI market, valued at $428 billion in 2022, is anticipated to reach $2.25 trillion by 2030, with a compound annual growth rate (CAGR) ranging from 33.2% to 38.1%. The sector is expected to employ 97 million individuals by 2025, reflecting its expansive and significant impact. This potential growth presents a compelling opportunity for investors and industry professionals interested in the AI sector.

Forward-Looking Statements

This press release includes forward-looking statements under federal securities laws, including projections and expectations regarding business developments, operations, and market conditions. These statements are identified by terms such as "should," "may," "intends," "anticipates," and others. While based on reasonable assumptions, results may differ due to various risks and uncertainties. Please review cautionary statements and disclosures in our filings with the SEC. The Company does not undertake any obligation to update forward-looking statements except as required by law.

For inquiries, please contact our CEO, Austen Lambrecht, at austen@1606corp.com.

Contact Information:

Austen Lambrecht
CEO
austen@1606corp.com

SOURCE: 1606 Corp.

$ILLR With over 430M+ consumer accounts and a reach of 100M+ social media users, Triller Group is redefining how content is created and shared. Our platform integrates AI and machine learning to deliver unparalleled experiences.

https://x.com/triller_IR/status/1849805614387691849

$ILLR Opportunity for Triller to take market share from TikTok!!!

$CANB Reorganization Announcement:
https://www.globenewswire.com/news-release/2024/10/30/2971617/0/en/Can-B-Corp-Announces-Holding-Company-Reorganization-With-Nascent-Pharma-Holdings-Inc-to-Become-the-Publicly-Traded-Parent-Company.html

$ILLR Triller, "We aim to become a global powerhouse in digital media surpassing TikTok".

$CBDW: Adnexus Biotechnologies Unveils Sutra(TM), a Game-Changing AI Platform for Drug Discovery and Infectious Disease Research

DALLAS, TX / ACCESSWIRE / October 1, 2024 / Adnexus Biotechnologies Inc., a pioneering company in Artificial Intelligence-driven innovations for early drug discovery and infectious disease research, is pleased to announce its new AI Empowered Drug Discovery Platform, Sutra™.

https://www.accesswire.com/imagelibrary/0ba2a55f-87c0-4f57-b991-9a3a312c6109/925182/12084.png

The Sutra™ AI platform has not just confirmed decades of work, but also added new targets for monoclonal antibodies within weeks, receiving independent validation of their potential from collaborators. Adnexus Biotechnologies Inc.'s AI algorithms have identified several promising drug candidates. The company has identified a target in the mitochondrial metabolism that has a role in oncology. The company then adds them to an ever-growing IP portfolio, including patents, trademarks, and trade secrets, enhancing its competitive advantage and potential for future revenue. The success and validation of the Sutra™ AI platform for AI-discovered drugs are testaments to its capabilities and the future it promises.

Adnexus Biotechnologies Inc. is dedicated to pushing the boundaries of drug discovery with its AI Drug Discovery (AIDD) player, Sutra™. With its AI-powered structure prediction algorithms, this platform has the potential to revolutionize drug discovery. It can design small molecules, optimize the design of antibodies and other proteins, and even repurpose drug molecules. With a database of 19 viruses, the Sutra™ AI platform can predict and help prevent future pandemics. With access to a curated library of 8 million molecules, the platform makes possible the discovery of new drugs that precisely target neutralizable epitopes on viruses to enhance the potency and efficacy of existing therapies. The Sutra™ team's unwavering dedication to leveraging microbiome samples to identify new biomarkers for neurodegenerative diseases instills hope for future medical breakthroughs.

Adnexus Biotechnologies Inc. harnesses the power of AI to revolutionize drug repurposing, offering a cost-effective alternative to developing new drugs from the ground up. Drug repurposing involves identifying potential new applications for existing compounds, which can be time-consuming and labor-intensive. However, AI algorithms can analyze existing drug databases and identify potential new applications for these compounds in a fraction of the time, making it a game-changer in the pharmaceutical industry. Adnexus is exploring synergizing AI with suitable linkers between antibodies and drugs to promote multi-drug combinations. This approach will bring new therapeutics to market with more substantial impacts than combination therapies and address unmet medical needs, expediting drug discovery and regulatory approvals.

Gaurav Chandra, the CEO of Adnexus Biotechnologies Inc., stated, "Our innovative use of AI reflects a broader trend toward embracing advanced technologies to overcome traditional limitations in the biotech industry. We are very excited about our AI-empowered drug discoveries. Adnexus is proud to introduce and implement the latest Artificial Intelligence innovations in research and development technology-keeping the company at the forefront of early drug discovery and development and other revolutionary discoveries critical to treating infectious diseases."

Dr. Chandra continued, "As we advance our HIV therapeutics, we intend to offer our expertise as unique SAAS and DAAS revenue-generating models by next year. This strategic move is part of our commitment to pursuing multiple revenue-generating strategies to broaden our offerings and support academic and biotechnology companies in advancing their scientific endeavors. This commitment underscores our financial stability and growth potential."

Adnexus has recently executed a Letter of Intent with 1606 Corp (OTC PINK:CBDW), an AI technology company, for a strategic investment in the company.

About Adnexus Biotechnologies Inc.

Adnexus is a leading innovator in biotechnology, specializing in AI-driven solutions for early drug discovery, infectious disease, and neurodegenerative disease research. Its proprietary methods focus on developing therapeutic solutions by leveraging human immune-B cells, offering a cutting-edge approach to creating highly effective treatments. For more information, please visit https://www.adnexusbiotech.com.

Industry Information

The global market size for artificial intelligence in drug discovery was estimated at USD 1.5 billion in 2023 and is projected to grow at a CAGR of 29.7% from 2024 to 2030. The demand for AI-powered solutions in drug discovery is increasing due to the need for new drug therapies, expanded manufacturing capacities in the life sciences industry, and technological advancements. AI technologies such as machine learning and deep learning are being used at various stages of drug discovery, including initial compound screening and predicting success rates in clinical trials. Additionally, the growth of startups developing AI-powered solutions and increased investments and funding drive market expansion.

Forward-Looking Statements

This press release includes forward-looking statements under federal securities laws, including projections and expectations regarding business developments, operations, and market conditions. These statements are identified by terms such as "should," "may," "intends," "anticipates," and others. While based on reasonable assumptions, results may differ due to various risks and uncertainties. Please review cautionary statements and disclosures in our filings with the SEC. Adnexus does not undertake any obligation to update forward-looking statements except as required by law.

For inquiries, please get in touch with Dr. Gaurav Chandra, CEO, gaurav.chandra@adnexusbiotech.com.

https://www.adnexusbiotech.com

http://www.cbdw.ai

Contact Information

Gaurav Chandra
CEO
gaurav.chandra@adnexusbiotech.com

SOURCE: Adnexus Biotechnologies Inc.

💲 $ILLR Bare_Knuckle_Fighting_Championship BKFC is the Next UFC

BKFC is Majority Owned by Triller and Valued at $411 Million.

RDAR.....NEWS NEWS NEWS: Raadr, Inc. Announces Agreement with Shareholders for the Cancellation of 1.7 Billion Common Shares and Affirms No Reverse Split
Press Release | 10/18/2024
NEW YORK, NY / ACCESSWIRE / October 18, 2024 / Raadr, Inc. (OTC Pink:RDAR) ("Raadr" or the "Company") is pleased to announce that it has reached a definitive agreement with certain shareholders for the cancellation of 1.7 billion common shares. This strategic decision reflects the Company's commitment to enhancing shareholder value by optimizing its capital structure. In addition, Raadr has opted not to pursue a reverse stock split at this time. The Company believes that the current capital structure provides significant potential for unlocking shareholder value, positioning Raadr for future growth without the need for such a measure.

$CBDW https://x.com/CBDWInc/status/1846556773655941508

💲 $AGBA All Steps Have Been Finalized To Move Towards The Completion Of This $4 Billion Mega Merger! Merger Completes This Monday After The Market Close!

$CBDW News! Join 1606 Corp.'s Exclusive Live Investor Webinar and Q&A Session on October 10th
SEATTLE, WA / ACCESSWIRE / October 7, 2024 /1606 Corp. (OTC PINK:CBDW) (the "Company," "1606," or "CBDW"), a leader in innovative AI chatbot solutions, is pleased to invite investors to a webinar on October 10, 2024, at 4:15 p.m. ET.

The exclusive event, hosted by RedChip Companies, will feature CBDW's CEO, Austen Lambrecht, who will share insight into the Company's innovative product portfolio and near-term expansion plans.

https://finance.yahoo.com/news/join-1606-corp-exclusive-live-120000748.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr

3 MILLION SHARES x .034=$102,000-WOW-BREAKOUT- https://www.stocktitan.net/news/ICBU/i-md-companies-inc-completes-acquisition-of-riize-ulbrsk3t40pj.html

$ICBU OCTOBER BREAKOUT -https://seekingalpha.com/pr/19836366-imd-companies-inc-subsidiary-riize-llc-to-expand-product-line-contracted-telemedicine-doctors

AMAZING 🤩 CHART— https://www.barchart.com/stocks/quotes/ICBU/opinion

$AIMD Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention
Link: https://finance.yahoo.com/news/ainos-secures-taiwan-invention-patent-123000316.html

$YGMZ News: MingZhu Logistics to Acquire HOLDCO 36 in Transformational Business Combination

SHENZHEN, China, Sept. 12, 2024 /PRNewswire/ -- MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (Nasdaq: YGMZ), an elite provider of logistics and transportation services to businesses, today announced the acquisition of HOLDCO 36 in a transformational business combination. The closing of the all-stock acquisition is subject to customary closing conditions, including regulatory approvals.

Mr. Jinlong Yang, Chairman and Chief Executive Officer of MingZhu, commented, "As part of our active M&A process, we have evaluated a series of potential transactions, with regard to long-term potential, valuation, and alignment with building shareholder value. We are excited about the proposed acquisition of HOLDCO 36 because it would immediately transform our business into higher growth, burgeoning market segments with a favorable regulatory environment and underlying demand catalysts. Upon successful deal closure and integration, we would expect to see a meaningful creation of value for all shareholders."

For assets and projects being injected, parties are with explicit understanding that the projects contributed by HOLDCO 36 and their conditions may change but new projects are always being secured and developed to either be added or be replacing non-active ones. Initial business assets and operations being acquired are expected to include:

Green Fuel Smart Trading Platform: A comprehensive global distribution platform for biofuels, natural gas, hydrogen-based fuels, methanol, and related equipment. This platform aims to establish itself as the OPEC of green biofuels, facilitating the trade and distribution of sustainable fuel sources worldwide.
EPC+O: Engineering, Procurement, Construction, and Operations for biomass energy, and new energy systems such as wind, solar, storage, hydrogen, and ammonia EPC engineering productions systems. Using the existing ECaaS to provide distributed biomass "carbon-electricity-biomass energy" co-generation solutions. The business provides wind, solar, storage, green hydrogen, and green ammonia and green fuel EPC consulting services to clients in Americas, Asia, Africa and Europe.

Power Leasing and Energy: Developed an intelligent financial service platform for sales and lease financing for green and lightweight vessels, maritime equipment and lightweight materials for vessels.

Digital Energy Services Segment for the Steel Industry: Innovating a smart virtual power plant for closed-loop virtual scenarios targeting steel mills worldwide, supporting local distributed energy operations and usage. Managing national zero-carbon industrial parks for the steel industry and voluntary carbon reduction, which provides carbon credit, supply chain carbon verification, green certificate trading and verification.

About MingZhu Logistics Holdings Limited (Nasdaq: YGMZ)

Established in 2002 and headquartered in Shenzhen, China, MingZhu Logistics Holdings Limited is a 4A-rated professional trucking service provider. Based on the Company's regional logistics terminals in Guangdong Province, MingZhu Logistics Holdings offers tailored solutions to our clients to deliver their goods through our network density and broad geographic coverage across the country by a combination of self-owned fleets tractors and trailers and subcontractors' fleets. For more information, please visit http://ir.szygmz.com.

Forward-Looking Statements

The statements in this press release regarding the Company's future expectations, plans and prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding plans, goals, objectives, strategies, future events, expected performance, assumptions and any other statements of fact that have not occurred. Any statements that contain the words "may", "will", "want", "should", "believe", "expect", "anticipate", "estimate", "calculate" or similar statements that are not factual in nature are to be considered forward-looking statements. Actual results may differ materially from historical results or from those expressed in these forward-looking statements as a result of a variety of factors. These factors include, but are not limited to, the Company's strategic objectives, the Company's future plans, market demand and user acceptance of the Company's products or services, technological advances, economic trends, the growth of the trucking services market in China, the Company's reputation and brand, the impact of industry competition and bidding, relevant policies and regulations, fluctuations in China's macroeconomic conditions, and the risks and assumptions disclosed in the Company's reports provided to the CSRC (China Security Regulatory Commission). The potential acquisition involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements including but not limited to statements about the potential benefits of the potential acquisition; the anticipated timing of closing of the potential acquisition (including failure to obtain necessary regulatory approvals) and the possibility that the potential acquisition does not close; risks related to the ability to realize the anticipated benefits of the potential acquisition, including the possibility that the expected benefits from the proposed transaction will not be realized or will not be realized within the expected time period; the risk that the businesses will not be integrated successfully; disruption from the potential acquisition making it more difficult to maintain business and operational relationships; negative effects of announcing the potential acquisition or the consummation of the potential acquisition on the market price of our common stock or operating results; costs associated with the potential acquisition; unknown liabilities; and the risk of litigation and/or regulatory actions related to the potential acquisition. For these and other related reasons, we advise investors not to place any reliance on these forward-looking statements, and we urge investors to review the Company's relevant SEC filings for additional factors that may affect the Company's future results of operations. The Company undertakes no obligation to publicly revise these forward-looking statements subsequent to the filing of these documents as a result of changes in particular events or circumstances.

https://c212.net/c/img/favicon.png?sn=CN05051&sd=2024-09-12 View original content:https://www.prnewswire.com/news-releases/mingzhu-logistics-to-acquire-holdco-36-in-transformational-business-combination-302246593.html

SOURCE MingZhu Logistics Holdings Limited

$BLQC Daily Chart https://stockcharts.com/c-sc/sc?s=blqc&w=520&i=p67382559859&r=1725982658443

$MVCO: Metavesco Executes Letter of Intent to Acquire Striped Pig Distillery and Local Choice Spirits

CUMMING, Ga., Aug. 16, 2024 /PRNewswire/ -- Metavesco, Inc. (OTC PINK:MVCO), a web3 enterprise and digital asset innovator, today announced the execution of a non-binding Letter of Intent (LOI) to acquire Striped Pig Distillery and Local Choice Spirits of Charleston.

Founded as one of South Carolina's oldest distilleries, Striped Pig Distillery has garnered multiple awards for its exceptional craft spirits. Local Choice Spirits has established a reputation for innovation and quality, solidifying its place in the market.

The two companies are led by visionary entrepreneur "Pixie" Paula Dezzutti. Pixie is recognized as a top influencer in SC in 2024, listed by Forbes as "Top 50 Over 50" in 2023, and recipient of the International Woman of the Year Award by the Atlanta Chamber of Commerce in 2022. She has been a prominent figure in the industry, not only for her business acumen but also for her contributions to the broader business community. Listed by INC 5000 as one of the fastest growing companies of the Southeast, and SC Top 50 Fastest Growing Businesses, Local Choice and Striped Pig have plans to unveil an event center for its patrons. Upon closing this transaction, Ms. Dezzutti will be appointed as Chief Executive Officer of Metavesco, Inc.

Post acquisition, the businesses will operate as wholly owned subsidiaries of Metavesco, Inc. Highlights of the combined businesses include:

Approximately 1000 barrels of aged bourbon, valued at over $18,000,000 retail
16 active product skus including vodkas, rums, gins, whiskeys, and tequila
Product distribution in 20 states and ecommerce availability in most
Distillery capable of producing 300 high quality bourbon barrels annually
World class management team with over 100 years combined industry experience
At closing, Metavesco will issue a combination of 2-year restricted common stock, preferred stock, and a 2-year convertible note in the amount of $2 million. Additionally, the Company will assume approximately $1.2 million in debt owed collectively by the acquired businesses.

Metavesco, Inc. CEO Ryan Schadel stated, "I'd like to say this was a tough decision since it means I'll be stepping down as CEO, but it wasn't a tough decision at all! Ms. Dezzutti's appointment as CEO will be a huge win for shareholders and she is poised to usher in a new era of innovation and growth. With a distinguished career that spans entrepreneurial success, industry recognition, and thought leadership, Pixie has consistently demonstrated an extraordinary ability to drive transformation and excellence. Her accolades, including her role as a featured panelist at the Atlanta Chamber of Commerce's seminar on NFTs, cryptocurrencies, and Blockchain 3.0, along with her Amazon best-selling book, Alphabet Soup, outlining her pioneering NFT Bourbon release, underscore her forward-thinking approach and deep industry insight. She's a force to be reckoned with and I believe Metavesco shareholders will be in good hands with her at the helm."

Ms. Dezzutti stated, "Our team at Striped Pig Distillery and Local Choice Spirits has dedicated years to perfecting our craft, building a strong, regional brand of which we're incredibly proud. This acquisition is the perfect opportunity to expand our reach and bring award-winning spirits to a national audience. The multi trillion-dollar beverage business needs pioneers to lead the charge in a quickly paced changing landscape. I am excited to lead Metavesco into this new era of growth and innovation and am confident that together we will achieve extraordinary success."

While there is no guarantee that a deal will be finalized, all parties are working aggressively to prepare and execute a definitive purchase agreement with a 30-day closing deadline.

About Metavesco

Metavesco is a web3 enterprise and digital asset innovator. The Company has bitcoin mining operations at hosted facilities in KY and IA. Through its wholly owned subsidiary, the Company operates Boring Brew, a specialty coffee company utilizing owned and licensed NFT IP as unique packaging.

Safe Harbor Statement

This press release contains statements that constitute forward-looking statements. These statements appear in a number of places in this press release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; and (iii) growth strategy and operating strategy. The words "may", "would", "will", "expect", "estimate", "can", "believe", "potential", and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is included in the Company's filings on otcmarkets.com.

Cision View original content:https://www.prnewswire.com/news-releases/metavesco-executes-letter-of-intent-to-acquire-striped-pig-distillery-and-local-choice-spirits-302223852.html

SOURCE Metavesco, Inc.